Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Huma, Dar"'
Autor:
Annelie, Johansson, Huma, Dar, Laura J, van 't Veer, Nicholas P, Tobin, Gizeh, Perez-Tenorio, Anna, Nordenskjöld, Ulla, Johansson, Johan, Hartman, Lambert, Skoog, Christina, Yau, Christopher C, Benz, Laura J, Esserman, Olle, Stål, Bo, Nordenskjöld, Tommy, Fornander, Linda S, Lindström
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(35)
To assess the long-term (20-year) endocrine therapy benefit in premenopausal patients with breast cancer.Secondary analysis of the Stockholm trial (STO-5, 1990-1997) randomly assigning 924 premenopausal patients to 2 years of goserelin (3.6 mg subcut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1466cee0e972871585d170bf76b535f
https://pubmed.ncbi.nlm.nih.gov/35862873
https://pubmed.ncbi.nlm.nih.gov/35862873
Autor:
Oscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, Anna Nordenskjöld, Christina Yau, Christopher C. Benz, Laura J. Esserman, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Annelie Johansson, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P3-05
Background: Women with estrogen receptor (ER)-positive disease have a long-term risk of distant recurrence. The poor survival of premenopausal women diagnosed with breast cancer combined with the otherwise long life expectancy makes it especially imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69bfc0b7d540b1622e48ebfa15beea7c
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-03
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-03
Autor:
Annelie Johansson, Huma Dar, Anna Nordenskjöld, Gizeh Perez-Tenorio, Christina Yau, Christopher C. Benz, Laura J. Esserman, Laura Van’t Veer, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P2-03
Background: Tamoxifen is a standard endocrine therapy for both pre- and postmenopausal ER-positive breast cancer patients. Patients with ER-positive disease have a long-term risk of distant recurrence, thus, long-term follow-up studies are essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d10b49254739aa912af151196de63280
https://doi.org/10.1158/1538-7445.sabcs22-p2-03-11
https://doi.org/10.1158/1538-7445.sabcs22-p2-03-11
Autor:
Huma Dar, Annelie Johansson, Anna Nordenskjöld, Gizeh Perez-Tenorio, Christina Yau, Christopher C. Benz, Laura J. Esserman, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P2-03
Background: The risk for patients with estrogen receptor (ER)-positive breast cancer remains stable decades after primary diagnosis, with a large proportion of distant metastatic events occurring late. Thus, long-term follow-up studies are essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13f1327a89437deb269b98dc6e75716d
https://doi.org/10.1158/1538-7445.sabcs22-p2-03-04
https://doi.org/10.1158/1538-7445.sabcs22-p2-03-04
Autor:
Huma, Dar, Annelie, Johansson, Anna, Nordenskjöld, Adina, Iftimi, Christina, Yau, Gizeh, Perez-Tenorio, Christopher, Benz, Bo, Nordenskjöld, Olle, Stål, Laura J, Esserman, Tommy, Fornander, Linda S, Lindström
Publikováno v:
JAMA network open. 4(6)
Clinically used breast cancer markers, such as tumor size, tumor grade, progesterone receptor (PR) status, and Ki-67 status, are known to be associated with short-term survival, but the association of these markers with long-term (25-year) survival i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::140d6e698e06f2cfc9fe2eccbfe94bf0
https://pubmed.ncbi.nlm.nih.gov/34191002
https://pubmed.ncbi.nlm.nih.gov/34191002
Autor:
LJ Esserman, Christina Yau, Anna Nordenskjöld, Anna L.V. Johansson, Gizeh Pérez-Tenorio, Huma Dar, Tommy Fornander, Olle Stål, L. Van ‘T Veer, Linda S. Lindström, Bo Nordenskjöld, Christopher C. Benz
Publikováno v:
Annals of Oncology. 32:S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a108c3b4b1b8a8f5c13ec5f1ce4d7ae
https://doi.org/10.1016/j.annonc.2021.03.210
https://doi.org/10.1016/j.annonc.2021.03.210
Autor:
Tommy Fornander, Anna L.V. Johansson, LJ Esserman, Adina Iftimi, Bo Nordenskjöld, Christopher C. Benz, Christina Yau, Linda S. Lindström, Olle Stål, Gizeh Pérez-Tenorio, Huma Dar, A. Nordensköljd
Publikováno v:
Annals of Oncology. 32:S23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d9c71e87ec6b69a686b74466f5fd806
https://doi.org/10.1016/j.annonc.2021.03.020
https://doi.org/10.1016/j.annonc.2021.03.020
Autor:
Huma Dar, Keith Humphreys, Kamila Czene, Jingmei Li, Yvonne Brandberg, Mikael Eriksson, Per Hall
Publikováno v:
International Journal of Cancer. 139:2415-2425
Literature focusing on health-related quality of life (HRQoL) by cancer site among women only is scarce. This study examines HRQoL of breast cancer (BC) survivors compared with female survivors of other cancers, and to understand which subgroups of B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e322576bb4dba51f997a59dc4b14e9fc
https://doi.org/10.1002/ijc.30370
https://doi.org/10.1002/ijc.30370
Autor:
Jingmei, Li, Keith, Humphreys, Mikael, Eriksson, Huma, Dar, Yvonne, Brandberg, Per, Hall, Kamila, Czene
Publikováno v:
International journal of cancer. 139(11)
Literature focusing on health-related quality of life (HRQoL) by cancer site among women only is scarce. This study examines HRQoL of breast cancer (BC) survivors compared with female survivors of other cancers, and to understand which subgroups of B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd1784a1cc1d32b298141dea4d647d9a
https://pubmed.ncbi.nlm.nih.gov/27486698
https://pubmed.ncbi.nlm.nih.gov/27486698